IFIT1+ Tumor-Associated Macrophages Suppress Cancer Stemness and Enhance Chemosensitivity via the TNFSF10–TNFRSF10B Axis in Epithelial Ovarian Cancer
Frontiers in Bioscience-Landmark · 2026
DOI: 10.31083/fbl52801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Rui Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine Sciences, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 310009 Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Carcinoma, Ovarian Epithelial, Neoplastic Stem Cells, Ovarian Neoplasms, TNF-Related Apoptosis-Inducing Ligand. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Pioneer" and "Leading Goose" R&D Program of Zhejiang, National Natural Science Foundation of China, “Pioneer” and “Leading Goose” R&D Program of Zhejiang.
Abstract (Originalsprache)
Background:Epithelial ovarian cancer (EOC) is typically diagnosed at an advanced stage and is associated with high mortality due to metastasis and chemoresistance. Cancer stem cells (CSCs) are central to EOC progression, recurrence, and treatment resistance, with their functional behavior shaped by the tumor immune microenvironment. While M1 and M2 macrophages have been well-characterized, the role of interferon-stimulated gene-enriched subpopulations, particularly interferon-induced protein with tetratricopeptide repeats 1 tumor-associated macrophages (IFIT1+ TAMs), in regulating CSC properties in EOC remains largely unexplored.Methods:Single-cell RNA sequencing (scRNA-seq) was utilized to map the myeloid landscape and trace transcriptomic evolution in EOC. An in vitro indirect culture model utilizing unpolarized macrophage (M0)-conditioned medium (CM) was established to assess baseline phenotypic alterations. Furthermore, targeted siRNA silencing (si-TNFRSF10B) combined with recombinant human tumor necrosis factor ligand superfamily member 10 (TNFSF10) (rhTRAIL) treatments were employed to evaluate the specific impact of the TNF-related apoptosis-inducing ligand (TRAIL)-Death receptor 5 (DR5) signaling axis on multidrug resistance and CD44 expression.Results:High-resolution scRNA-seq analysis revealed a stage-dependent decline in IFIT1+ TAMs, an interferon-primed subset that robustly expresses the TNFSF10 ligand during early-stage disease. In vitro assays showed that conditioned medium from M0 macrophages suppresses CSC features and enhances expression of the tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNFRSF10B/DR5) in EOC cells. Mechanistic studies confirmed that exogenous rhTRAIL treatment markedly diminished CD44+ cell populations and enhanced sensitivity to chemotherapeutic agents. Notably, these antitumor effects were largely abrogated following siRNA-mediated silencing of the DR5 receptor in EOC cell lines.Conclusions:Our findings reveal that IFIT1+ tumor-associated macrophages intrinsically harbor anti-cancer stem cell potential through the TNFSF10 ligand. Activation of the TNFSF10-TNFRSF10B pathway suppresses cancer stemness and may enhance chemosensitivity. These insights shed light on the functional diversity of macrophages, highlighting that driving tumor-associated macrophages toward a sustained, interferon-primed IFIT1+ phenotype represents a promising therapeutic approach to target cancer stem cell populations in epithelial ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medicine Sciences, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 310009 Hangzhou, Zhejiang, China.
- Department of Gynecology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 310009 Hangzhou, Zhejiang, China.
- Zhejiang Provincial Clinical Research Center for Gynecological Diseases, 310006 Hangzhou, Zhejiang, China.
- Key Laboratory of Cancer Invasion and Metastasis (HUST), Ministry of Education, 430100 Wuhan, Hubei, China.
- Clinical Research Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 310009 Hangzhou, Zhejiang, China.
- School of Basic Medical Sciences, Zhejiang University, 310058 Hangzhou, Zhejiang, China.
Förderung
- "Pioneer" and "Leading Goose" R&D Program of Zhejiang
- National Natural Science Foundation of China
- “Pioneer” and “Leading Goose” R&D Program of Zhejiang
Zitieren
APA
Liu, R., Fang, Y., Zheng, R., Lin, L., Huang, D., Zhai, L., He, Q., Zhang, Z., Zhou, J., & Zhang, X. (2026). IFIT1+ Tumor-Associated Macrophages Suppress Cancer Stemness and Enhance Chemosensitivity via the TNFSF10–TNFRSF10B Axis in Epithelial Ovarian Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl52801
Vancouver
Liu R, Fang Y, Zheng R, Lin L, Huang D, Zhai L, et al. IFIT1+ Tumor-Associated Macrophages Suppress Cancer Stemness and Enhance Chemosensitivity via the TNFSF10–TNFRSF10B Axis in Epithelial Ovarian Cancer. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl52801
BibTeX
@article{Liu2026,
author = {Liu, Rui and Fang, Yilin and Zheng, Ruxi and Lin, Liya and Huang, Da and Zhai, Lingyun and He, Qionghua and Zhang, Zhigang and Zhou, Jianwei and Zhang, Xiaoming},
title = {IFIT1+ Tumor-Associated Macrophages Suppress Cancer Stemness and Enhance Chemosensitivity via the TNFSF10–TNFRSF10B Axis in Epithelial Ovarian Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
doi = {10.31083/fbl52801}
}
EUVIMED